Promoter holding
64.27%
BL
Brussels Laboratories Pvt Ltd - Due diligence report
A 360° intelligence report on Brussels Laboratories Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and d…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Brussels Laboratories Pvt Ltd — 360° Intelligence Report
Generated from MCA filings & public records78/100
Trust Score
Low Risk
Brussels Laboratories Pvt Ltd is assessed as Low Risk with a Trust Score of 78/100. Brussels Laboratories Pvt Ltd is an active private limited indian non-government company incorporated in 1993, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Brussels Laboratories Pvt Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Liabilities ≈ 38% EBITDA - stretched.
- Open charges exceed net worth - secured lenders rank ahead.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 1 open (13.17 cr) · 8 satisfied (21.77 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 3 | 48.0 cr |
| The Kalupur Commercial Co-Operative Bank Limited | 1 | 48.0 cr |
| Central Bank Of India | 4 | 48.0 cr |
| Citicorp Finance India Ltd | 1 | 48.0 cr |
Compliance Score: 68/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- 1 auditor resignation(s) filed - latest: S.R.SANGHVI & CO. on 2021-08-28.
- Delayed payments to MSME suppliers disclosed (120 disclosure(s)).
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| RAJESH GOVIND MANDAVLE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RANDHIRKUMAR MADHAVLAL CHAUDHARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ASHOKBHAI CHELABHAI PATEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| URMILKUMAR RAMCHANDRA SONI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 2 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 65 · Distress 75
Growth signals & trust indicators
Profit expanded 1.42 year-on-year.
Net margin improved to 2.1x.
Operating for 32+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
1 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 98.86 Lakh.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence73/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 13.17 cr already registered.
- Compliance gaps should be priced into terms.
Investor view70/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Sep 2024
Director ceased
RANDHIRKUMAR MADHAVLAL CHAUDHARI
01 Mar 2024
Director appointed
RANDHIRKUMAR MADHAVLAL CHAUDHARI (Director)
25 Nov 2020
Charge satisfied
The Kalupur Commercial Co-Operative Bank Limited
17 Sep 2020
Charge created
Others - 13.17 cr
31 Mar 2020
Share transfer (FY 2020)
50200.00000000 shares to RANDHIRBHAI MADHAVLAL CHAUDHARI
22 May 2019
Securities allotted
129167 Equity Shares - 31.00 Lakh raised
31 Dec 2018
Charge satisfied
Others
26 Dec 2018
Charge satisfied
Others
01 Dec 2018
Charge created
The Kalupur Commercial Co-Operative Bank Limited - 7.13 cr
23 Nov 2018
Securities allotted
125000 Equity Shares - 30.00 Lakh raised
17 Oct 2017
Charge created
Others - 4.75 cr
30 Sep 2017
Director ceased
PRAVINBHAI RAMSANGBHAI CHAUDHARI
Director ceased
RAJESH GOVIND MANDAVLE
10
Key Observations
Auto-generated from the data aboveRevenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Swiss Pharma | U24231GJ1987PTC009343 | Ahmedabad, Gujarat, India |
| Acechemie Zynk Energy Limited | U24232GJ2015PLC085471 | Amod, Gujarat, India |
| Mmc Health Care Limited | U93090TN1996PLC034651 | Chennai, Tamil Nadu, India |
| Fenasia Limited | U65993WB1997PLC082448 | Bhadreshwar, West Bengal, India |
| Integrated Laboratories Private Limited | U24230HP2005PTC028062 | Distt Sirmour, Himachal Pradesh, India |
| Glide Chem Private Limited | U24211DL1998PTC094129 | New Delhi, Delhi, India |
| Nice Chemicals Private Limited | U24299KL1989PTC005294 | Ernakulam, Kerala, India |
| Renown Pharmaceuticals | U24230GJ2005PTC046714 | Vadodara, Gujarat, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Brussels Laboratories Pvt Ltd before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Brussels Laboratories Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Brussels Laboratories Pvt Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Brussels Laboratories Pvt Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Brussels Laboratories Pvt Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Brussels Laboratories Pvt Ltd an active company?
Brussels Laboratories Pvt Ltd has MCA status “Active” with a compliance score of 68/100 (Moderate).
Is Brussels Laboratories Pvt Ltd financially healthy?
Brussels Laboratories Pvt Ltd has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.
Should I do business with Brussels Laboratories Pvt Ltd?
Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Brussels Laboratories Pvt Ltd?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.
Does Brussels Laboratories Pvt Ltd have loans or charges against its assets?
1 open charge(s) are registered against its assets, and 8 earlier charge(s) stand satisfied.
Is Brussels Laboratories Pvt Ltd up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 68/100 (Moderate).
Is it risky to lend to Brussels Laboratories Pvt Ltd?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
